Financials

  • Market Capitalization 49.45 M
  • Employee 21
  • Founded 2015
  • CEO N/A
  • Website www.inmunebio.com
  • Headquarter Nevada, United States
  • FIGI BBG00LW94L98
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.84
Rapporto prezzo/fatturato
772.44

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4290
TCRT
Alaunos Therapeutics, Inc. - Common Stock
2.08 USD+1.46%+1.96%-12.24%-22.07%50.80 M USD
4303
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.32 USD+3.94%+5.60%+8.20%-8.33%49.69 M USD
4309
ATYR
aTyr Pharma, Inc. - Common Stock
0.50 USD-7.41%-27.54%+6.38%-48.45%49.03 M USD
4349
HYPD
Hyperion DeFi, Inc. - Common Stock
2.97 USD-3.88%-7.48%+3.12%-75.25%45.02 M USD

Notizie